Ástralía - enska - Department of Health (Therapeutic Goods Administration)

azure health products pty ltd - verbascum thapsus, quantity: 150 mg (equivalent: verbascum thapsus, qty 600 mg); astragalus membranaceus, quantity: 100 mg (equivalent: astragalus membranaceus, qty 1 g); andrographis paniculata, quantity: 75 mg (equivalent: andrographis paniculata, qty 1.05 g); thymus vulgaris, quantity: 50 mg (equivalent: thymus vulgaris, qty 200 mg); ganoderma lucidum, quantity: 50 mg (equivalent: ganoderma lucidum, qty 1 g); retinol palmitate, quantity: 350 microgram (equivalent: vitamin a, qty 191.05 re); selenomethionine, quantity: 0.01 mg (equivalent: selenium, qty 0.004 mg); calcium ascorbate dihydrate, quantity: 121.07 mg (equivalent: ascorbic acid, qty 100 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; acacia; silicon dioxide; maltodextrin; dextrin; sucrose; maize starch; butylated hydroxytoluene; calcium hydrogen phosphate; hypromellose; calcium hydrogen phosphate dihydrate; magnesium stearate; croscarmellose sodium; crospovidone; povidone; macrogol 400; chlorophyllin-copper complex; titanium dioxide; carnauba wax - helps enhance/promote general health and wellbeing ; maintain/support general health and wellbeing ; maintain/support immune system health ; maintain/support (state vitamin/mineral/nutrient) levels in the body ; maintain/support lung health

Sádi-Arabía - enska - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

tabuk pharmaceutical manufacturing company, saudi arabia - lacosamide - film-coated tablet - 50 mg

Sádi-Arabía - enska - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

tabuk pharmaceutical manufacturing company, saudi arabia - lacosamide - film-coated tablet - 100 mg

Sádi-Arabía - enska - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

tabuk pharmaceutical manufacturing company, saudi arabia - lacosamide - film-coated tablet - 200 mg

Írland - enska - HPRA (Health Products Regulatory Authority)

azure pharmaceuticals ltd - dosulepin hydrochloride - coated tablet - dosulepin

Bandaríkin - enska - NLM (National Library of Medicine)

mayne pharma inc. - desogestrel (unii: 81k9v7m3a3) (desogestrel - unii:81k9v7m3a3), ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u) - desogestrel 0.15 mg - azurette® (desogestrel/ethinyl estradiol and ethinyl estradiol tablets usp) is indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception. oral contraceptives are highly effective. table ii lists the typical accidental pregnancy rates for users of combination oral contraceptives and other methods of contraception. the efficacy of these contraceptive methods, except sterilization, depends upon the reliability with which they are used. correct and consistent use of these methods can result in lower failure rates. table ii: percentage of women experiencing an unintended pregnancy during the first year of typical use and the first year of perfect use of contraception and the percentage continuing use at the end of the first year, united states. % of women experiencing an unintended pregnancy within the first year of use % of women continuing use at one year * (4) method   (1) typical use † (2) perfect use ‡   (3) chance§   85 85 spermicides¶ 26 6 40 periodi

Bandaríkin - enska - NLM (National Library of Medicine)

rpk pharmaceuticals, inc. - desogestrel (unii: 81k9v7m3a3) (desogestrel - unii:81k9v7m3a3), ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u) - azurette® (desogestrel/ethinyl estradiol and ethinyl estradiol tablets usp) is indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception. oral contraceptives are highly effective. table ii lists the typical accidental pregnancy rates for users of combination oral contraceptives and other methods of contraception. the efficacy of these contraceptive methods, except sterilization, depends upon the reliability with which they are used. correct and consistent use of these methods can result in lower failure rates. table ii: percentage of women experiencing an unintended pregnancy during the first year of typical use and the first year of perfect use of contraception and the percentage continuing use at the end of the first year, united states. % of women experiencing an unintended pregnancy within the first year of use % of women continuing use at one year * (4) method   (1) typical use † (2) perfect use ‡   (3) chance§   85 85 spermicides¶ 26 6 40 periodi

Bandaríkin - enska - NLM (National Library of Medicine)

mayne pharma inc. - desogestrel (unii: 81k9v7m3a3) (desogestrel - unii:81k9v7m3a3), ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u) - azurette (desogestrel and ethinyl estradiol tablets, usp and ethinyl estradiol tablets, usp) is indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception. oral contraceptives are highly effective. table ii lists the typical accidental pregnancy rates for users of combination oral contraceptives and other methods of contraception. the efficacy of these contraceptive methods, except sterilization, depends upon the reliability with which they are used. correct and consistent use of these methods can result in lower failure rates. adapted from hatcher et al., 1998, ref#1. 1 among typical couples who initiate use of a method (not necessarily for the first time), the percentage who experience an accidental pregnancy during the first year if they do not stop use for any other reason. 2 among couples who initiate use of a method (not necessarily for the first time) and who use it perfectly (both consistently and correctly), the percentage who experience an accid

Bandaríkin - enska - NLM (National Library of Medicine)

rpk pharmaceuticals, inc. - desogestrel (unii: 81k9v7m3a3) (desogestrel - unii:81k9v7m3a3), ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u) - azurette (desogestrel and ethinyl estradiol tablets, usp and ethinyl estradiol tablets, usp) is indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception. oral contraceptives are highly effective. table ii lists the typical accidental pregnancy rates for users of combination oral contraceptives and other methods of contraception. the efficacy of these contraceptive methods, except sterilization, depends upon the reliability with which they are used. correct and consistent use of these methods can result in lower failure rates. adapted from hatcher et al., 1998, ref#1. 1 among typical couples who initiate use of a method (not necessarily for the first time), the percentage who experience an accidental pregnancy during the first year if they do not stop use for any other reason. 2 among couples who initiate use of a method (not necessarily for the first time) and who use it perfectly (both consistently and correctly), the percentage who experience an accid

Malta - enska - Medicines Authority

azure pharmaceuticals ltd 12 hamilton drive, the rock road, blackrock, co. louth a91 t997, ireland - colchicine - tablet - colchicine 500 µg - antigout preparations